je.st
news
Lilly beats forecast, helped by drug soon to face generics
2013-07-24 14:02:34| Biotech - Topix.net
Eli Lilly and Co reported higher-than-expected quarterly earnings, helped by cost cuts and strong sales growth of Cymbalta, a depression treatment that will soon lose patent protection, and the drugmaker raised its full-year profit forecast.
Tags: face
drug
helped
forecast
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|